CXCL13 inhibition induce the apoptosis of MDA-MB-231 breast cancer cells through blocking CXCR5/ERK signaling pathway.

Ma, J-J; Jiang, L; Tong, D-Y; Ren, Y-N; Sheng, M-F; Liu, H-C

Ma, J-J; Jiang, L; Tong, D-Y; Ren, Y-N; Sheng, M-F; Liu, H-C.

Affiliation

Ma JJ; Department of Oncology, the People's Liberation Army 107 Hospital, Yantai, Shandong, P.R. China. shengmengfei04@163.com.

Eur Rev Med Pharmacol Sci ; 22(24): 8755-8762, 2018 12.

Article in En | MEDLINE | ID: mdl-30575916

Subject(s)

Antineoplastic Agents/pharmacology; Apoptosis/drug effects; Chemokine CXCL13/antagonists & inhibitors; Signal Transduction/drug effects; Triple Negative Breast Neoplasms/drug therapy; Antineoplastic Agents/therapeutic use; Cell Line, Tumor; Chemokine CXCL13/metabolism; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases/metabolism; Female; Humans; Receptors, CXCR5/metabolism; Triple Negative Breast Neoplasms/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Signal Transduction / Apoptosis / Chemokine CXCL13 / Triple Negative Breast Neoplasms / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2018 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google